speb/financial-data huggingface dataset:
UCB balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2700674000.00
UCB balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 21308210000.00
UCB income_statement (annual, 2022-12-31) — Total Unusual Items: -19375000.00
UCB income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -19375000.00
UCB income_statement (annual, 2023-12-31) — +Total Revenue: 871949000.00
UCB balance_sheet (annual, 2023-12-31) — Accounts Receivable: 87782000.00
UCB balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -177858000.00
UCB balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 2699112000.00
UCB income_statement (annual, 2023-12-31) — Amortization: 15175000.00
UCB income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 15175000.00
UCB cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
UCB income_statement (annual, 2023-12-31) — Basic Average Shares: 117603000.00
UCB income_statement (annual, 2023-12-31) — Basic EPS: 1.54
UCB cash_flow (annual, 2023-12-31) — Beginning Cash Position: 646853000.00
UCB balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 232321000.00
UCB cash_flow (annual, 2023-12-31) — Capital Expenditure: -72485000.00
UCB balance_sheet (annual, 2023-12-31) — Capital Stock: 207276000.00
UCB balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 1003875000.00
UCB balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 1003875000.00
UCB cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -111720000.00
UCB balance_sheet (annual, 2023-12-31) — Cash Financial: 200781000.00
UCB cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 226340000.00
UCB cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -163289000.00
UCB cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 293971000.00
UCB cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -20504000.00
UCB cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -49649000.00
UCB cash_flow (annual, 2023-12-31) — Change In Working Capital: -87474000.00
UCB cash_flow (annual, 2023-12-31) — Changes In Cash: 357022000.00
UCB balance_sheet (annual, 2023-12-31) — Common Stock: 119010000.00
UCB cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -105085000.00
UCB balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3173259000.00
UCB cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
UCB balance_sheet (annual, 2023-12-31) — Construction In Progress: 71435000.00
UCB cash_flow (annual, 2023-12-31) — Deferred Income Tax: 6389000.00
UCB cash_flow (annual, 2023-12-31) — Deferred Tax: 6389000.00
UCB cash_flow (annual, 2023-12-31) — Depreciation: 44963000.00
UCB cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 44963000.00
UCB income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 15175000.00
UCB cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 44963000.00
UCB income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 15175000.00
UCB balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 84811000.00
UCB income_statement (annual, 2023-12-31) — Diluted Average Shares: 117745000.00
UCB income_statement (annual, 2023-12-31) — Diluted EPS: 1.54
UCB income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 180847000.00
UCB cash_flow (annual, 2023-12-31) — End Cash Position: 1003875000.00
UCB cash_flow (annual, 2023-12-31) — Financing Cash Flow: 226340000.00
UCB cash_flow (annual, 2023-12-31) — Free Cash Flow: 221486000.00
UCB cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 53333000.00
UCB income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -50823000.00
UCB balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -239192000.00
UCB income_statement (annual, 2023-12-31) — General And Administrative Expense: 345913000.00
UCB balance_sheet (annual, 2023-12-31) — Goodwill: 919914000.00
UCB balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 990087000.00
UCB balance_sheet (annual, 2023-12-31) — Gross PPE: 556279000.00
UCB balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 2490848000.00
UCB income_statement (annual, 2023-12-31) — Insurance And Claims: 27449000.00
UCB income_statement (annual, 2023-12-31) — Interest Expense: 419342000.00
UCB income_statement (annual, 2023-12-31) — Interest Income: 1237107000.00
UCB balance_sheet (annual, 2023-12-31) — Invested Capital: 3498082000.00
UCB cash_flow (annual, 2023-12-31) — Investing Cash Flow: -163289000.00
UCB balance_sheet (annual, 2023-12-31) — Investments And Advances: 5821932000.00
UCB cash_flow (annual, 2023-12-31) — Issuance Of Debt: 2225000000.00
UCB balance_sheet (annual, 2023-12-31) — Land And Improvements: 114368000.00
UCB balance_sheet (annual, 2023-12-31) — Long Term Debt: 324823000.00
UCB balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 324823000.00
UCB cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 2225000000.00
UCB cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -2870000000.00
UCB balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 138155000.00
UCB cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 113953000.00
UCB cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
UCB income_statement (annual, 2023-12-31) — Net Income: 187544000.00
UCB income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 180847000.00
UCB income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 187544000.00
UCB income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 187544000.00
UCB income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 187544000.00
UCB cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 187544000.00
UCB income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 187544000.00
UCB income_statement (annual, 2023-12-31) — Net Interest Income: 817765000.00
UCB cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 780456000.00
UCB cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -992615000.00
UCB cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -645000000.00
UCB cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -815000.00
UCB cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 11307000.00
UCB balance_sheet (annual, 2023-12-31) — Net PPE: 378421000.00
UCB cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -72485000.00
UCB cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: -7151000.00
UCB cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -347615000.00
UCB balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 2271438000.00
UCB income_statement (annual, 2023-12-31) — Normalized Income: 209475260.00
UCB income_statement (annual, 2023-12-31) — Occupancy And Equipment: 85904000.00
UCB cash_flow (annual, 2023-12-31) — Operating Cash Flow: 293971000.00
UCB cash_flow (annual, 2023-12-31) — Operating Gains Losses: 44187000.00
UCB income_statement (annual, 2023-12-31) — Operating Revenue: 871949000.00
UCB balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 119010319.00
UCB balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -239192000.00
UCB balance_sheet (annual, 2023-12-31) — Other Equity Interest: 13110000.00
UCB balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 70173000.00
UCB income_statement (annual, 2023-12-31) — Other Non Interest Expense: 39567000.00
UCB balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 3331084000.00
UCB income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 62000.00
UCB balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 3662000.00
UCB balance_sheet (annual, 2023-12-31) — Preferred Stock: 88266000.00
UCB cash_flow (annual, 2023-12-31) — Preferred Stock Dividend Paid: -6635000.00
UCB income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 6635000.00
UCB balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 88266000.00
UCB cash_flow (annual, 2023-12-31) — Preferred Stock Payments: -7151000.00
UCB income_statement (annual, 2023-12-31) — Pretax Income: 232545000.00
UCB income_statement (annual, 2023-12-31) — Professional Expense And Contract Services Expense: 26732000.00
UCB cash_flow (annual, 2023-12-31) — Purchase Of Business: -93613000.00
UCB cash_flow (annual, 2023-12-31) — Purchase Of Investment: -1000176000.00
UCB cash_flow (annual, 2023-12-31) — Purchase Of PPE: -72485000.00
UCB balance_sheet (annual, 2023-12-31) — Receivables: 87782000.00
UCB income_statement (annual, 2023-12-31) — Reconciled Depreciation: 44963000.00
UCB cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2870000000.00
UCB cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -7151000.00
UCB income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 27210000.00
UCB balance_sheet (annual, 2023-12-31) — Retained Earnings: 581219000.00
UCB income_statement (annual, 2023-12-31) — Salaries And Wages: 318464000.00
UCB cash_flow (annual, 2023-12-31) — Sale Of Business: 207566000.00
UCB cash_flow (annual, 2023-12-31) — Sale Of Investment: 1780632000.00
UCB cash_flow (annual, 2023-12-31) — Sale Of PPE: 4665000.00
UCB income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 9473000.00
UCB income_statement (annual, 2023-12-31) — Selling General And Administration: 355386000.00
UCB balance_sheet (annual, 2023-12-31) — Share Issued: 119010319.00
UCB income_statement (annual, 2023-12-31) — Special Income Charges: -27210000.00
UCB cash_flow (annual, 2023-12-31) — Stock Based Compensation: 8932000.00
UCB balance_sheet (annual, 2023-12-31) — Stockholders Equity: 3261525000.00
UCB balance_sheet (annual, 2023-12-31) — Tangible Book Value: 2183172000.00
UCB income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -5278740.00
UCB income_statement (annual, 2023-12-31) — Tax Provision: 45001000.00
UCB income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.19
UCB balance_sheet (annual, 2023-12-31) — Total Assets: 27297251000.00
UCB balance_sheet (annual, 2023-12-31) — Total Capitalization: 3586348000.00
UCB balance_sheet (annual, 2023-12-31) — Total Debt: 324823000.00
UCB balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3261525000.00
UCB balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 24035726000.00
UCB income_statement (annual, 2023-12-31) — Total Unusual Items: -27210000.00
UCB income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -27210000.00
UCB balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
UCB cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
UCB cash_flow (quarterly, 2024-09-30) — Change In Accrued Expense: -68520000.00
UCB cash_flow (quarterly, 2024-09-30) — Change In Payables And Accrued Expense: -68520000.00
UCB cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
UCB balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 12661000.00
UCB balance_sheet (quarterly, 2024-09-30) — Preferred Shares Number: 3662000.00
UCB balance_sheet (quarterly, 2024-09-30) — Preferred Stock Equity: 88266000.00
UCB cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 615000.00
UCB cash_flow (quarterly, 2024-09-30) — Short Term Debt Payments: 0.00
UCB income_statement (annual, 2024-12-31) — +Total Revenue: 930042000.00
UCB balance_sheet (annual, 2024-12-31) — Accounts Receivable: 85616000.00
UCB balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 85616000.00
UCB balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -179100000.00
UCB balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -179100000.00
UCB balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 2723278000.00
UCB income_statement (annual, 2024-12-31) — Amortization: 14596000.00
UCB income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 14596000.00
UCB cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 5100000.00
UCB cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
UCB income_statement (annual, 2024-12-31) — Basic Average Shares: 119783000.00
UCB income_statement (annual, 2024-12-31) — Basic EPS: 2.04
UCB cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1003875000.00
UCB balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 300928000.00
UCB balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 300928000.00
UCB cash_flow (annual, 2024-12-31) — Capital Expenditure: -47044000.00
UCB balance_sheet (annual, 2024-12-31) — Capital Stock: 207630000.00
UCB balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 519873000.00
UCB balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 519873000.00
UCB cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -118609000.00
UCB balance_sheet (annual, 2024-12-31) — Cash Financial: 296161000.00
UCB cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 157306000.00
UCB cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -991042000.00
UCB cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 349734000.00
UCB cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 8815000.00
UCB cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -24266000.00
UCB cash_flow (annual, 2024-12-31) — Change In Working Capital: -39977000.00
UCB cash_flow (annual, 2024-12-31) — Changes In Cash: -484002000.00
UCB balance_sheet (annual, 2024-12-31) — Common Stock: 119364000.00
UCB cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -112316000.00
UCB balance_sheet (annual, 2024-12-31) — Common Stock Equity: 3343861000.00
UCB cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
UCB balance_sheet (annual, 2024-12-31) — Construction In Progress: 4634000.00
UCB balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 4634000.00
UCB cash_flow (annual, 2024-12-31) — Deferred Income Tax: 7196000.00
UCB cash_flow (annual, 2024-12-31) — Deferred Tax: 7196000.00
UCB cash_flow (annual, 2024-12-31) — Depreciation: 40930000.00
UCB cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 40930000.00
UCB income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 14596000.00
UCB cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 40930000.00
UCB income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 14596000.00
UCB balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 77834000.00
UCB balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 77834000.00
UCB income_statement (annual, 2024-12-31) — Diluted Average Shares: 119900000.00
UCB income_statement (annual, 2024-12-31) — Diluted EPS: 2.04
UCB income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 244626000.00
UCB cash_flow (annual, 2024-12-31) — End Cash Position: 519873000.00
UCB cash_flow (annual, 2024-12-31) — Financing Cash Flow: 157306000.00
UCB cash_flow (annual, 2024-12-31) — Free Cash Flow: 302690000.00
UCB cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 3316000.00
UCB income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 6805000.00
UCB balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -212919000.00
UCB income_statement (annual, 2024-12-31) — General And Administrative Expense: 361021000.00
UCB balance_sheet (annual, 2024-12-31) — Goodwill: 907090000.00
UCB balance_sheet (quarterly, 2024-12-31) — Goodwill: 907090000.00
UCB balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 956643000.00
UCB balance_sheet (annual, 2024-12-31) — Gross PPE: 573364000.00
UCB balance_sheet (quarterly, 2024-12-31) — Gross PPE: 573364000.00
UCB balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 2368107000.00
UCB income_statement (annual, 2024-12-31) — Insurance And Claims: 20978000.00
UCB income_statement (annual, 2024-12-31) — Interest Expense: 550373000.00
UCB income_statement (annual, 2024-12-31) — Interest Income: 1377741000.00
UCB balance_sheet (annual, 2024-12-31) — Invested Capital: 3598013000.00
UCB cash_flow (annual, 2024-12-31) — Investing Cash Flow: -991042000.00
UCB balance_sheet (annual, 2024-12-31) — Investments And Advances: 6804398000.00
UCB cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1100000.00
UCB balance_sheet (annual, 2024-12-31) — Land And Improvements: 124969000.00
UCB balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 124969000.00
UCB balance_sheet (annual, 2024-12-31) — Long Term Debt: 254152000.00
UCB balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 254152000.00
UCB cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1100000.00
UCB cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -69657000.00
UCB balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 142833000.00
UCB balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 142833000.00
UCB cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 8592000.00
UCB cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 8592000.00
UCB cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
UCB income_statement (annual, 2024-12-31) — Net Income: 252397000.00
UCB income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 244626000.00
UCB income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 252397000.00
UCB income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 252397000.00
UCB income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 252397000.00
UCB cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 252397000.00
UCB income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 252397000.00
UCB income_statement (annual, 2024-12-31) — Net Interest Income: 827368000.00
UCB cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -1053718000.00
UCB cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 126443000.00
UCB cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -68557000.00
UCB cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -13000.00
UCB cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 18412000.00
UCB balance_sheet (annual, 2024-12-31) — Net PPE: 394264000.00
UCB cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -47044000.00
UCB cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -5014000.00
UCB cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
UCB cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 195000000.00
UCB balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2475484000.00
UCB income_statement (annual, 2024-12-31) — Normalized Income: 259131563.00
UCB income_statement (annual, 2024-12-31) — Occupancy And Equipment: 93555000.00
UCB cash_flow (annual, 2024-12-31) — Operating Cash Flow: 349734000.00
UCB cash_flow (annual, 2024-12-31) — Operating Gains Losses: 22334000.00
UCB income_statement (annual, 2024-12-31) — Operating Revenue: 930042000.00
UCB balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 119364110.00
UCB balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -212919000.00
UCB balance_sheet (annual, 2024-12-31) — Other Equity Interest: 12999000.00
UCB balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 12999000.00
UCB balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 49553000.00
UCB balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 49553000.00
UCB income_statement (annual, 2024-12-31) — Other Non Interest Expense: 45012000.00
UCB balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 4436291000.00
UCB income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 1478000.00
UCB balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 3662000.00
UCB balance_sheet (quarterly, 2024-12-31) — Preferred Shares Number: 3662000.00
UCB balance_sheet (annual, 2024-12-31) — Preferred Stock: 88266000.00
UCB balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 88266000.00
UCB cash_flow (annual, 2024-12-31) — Preferred Stock Dividend Paid: -6293000.00
UCB income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 6293000.00
UCB income_statement (quarterly, 2024-12-31) — Preferred Stock Dividends: 1574000.00
UCB balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 88266000.00
UCB balance_sheet (quarterly, 2024-12-31) — Preferred Stock Equity: 88266000.00
UCB cash_flow (annual, 2024-12-31) — Preferred Stock Payments: 0.00
UCB income_statement (annual, 2024-12-31) — Pretax Income: 323006000.00
UCB income_statement (annual, 2024-12-31) — Professional Expense And Contract Services Expense: 24732000.00
UCB cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
UCB cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
UCB cash_flow (annual, 2024-12-31) — Purchase Of Investment: -2056090000.00
UCB cash_flow (annual, 2024-12-31) — Purchase Of PPE: -47044000.00
UCB balance_sheet (annual, 2024-12-31) — Receivables: 85616000.00
UCB balance_sheet (quarterly, 2024-12-31) — Receivables: 85616000.00
UCB income_statement (annual, 2024-12-31) — Reconciled Depreciation: 40930000.00
UCB cash_flow (annual, 2024-12-31) — Repayment Of Debt: -69657000.00
UCB cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
UCB income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 8623000.00
UCB balance_sheet (annual, 2024-12-31) — Retained Earnings: 714138000.00
UCB income_statement (annual, 2024-12-31) — Salaries And Wages: 340043000.00
UCB cash_flow (annual, 2024-12-31) — Sale Of Business: 8592000.00
UCB cash_flow (quarterly, 2024-12-31) — Sale Of Business: 8592000.00
UCB cash_flow (annual, 2024-12-31) — Sale Of Investment: 1002372000.00
UCB cash_flow (annual, 2024-12-31) — Sale Of PPE: 1156000.00
UCB cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 525000.00
UCB income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 8546000.00
UCB income_statement (annual, 2024-12-31) — Selling General And Administration: 369567000.00
UCB balance_sheet (annual, 2024-12-31) — Share Issued: 119364110.00
UCB income_statement (annual, 2024-12-31) — Special Income Charges: -8623000.00
UCB cash_flow (annual, 2024-12-31) — Stock Based Compensation: 10803000.00
UCB balance_sheet (annual, 2024-12-31) — Stockholders Equity: 3432127000.00
UCB balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2387218000.00
UCB income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -1888437.00
UCB income_statement (annual, 2024-12-31) — Tax Provision: 70609000.00
UCB income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.22
UCB balance_sheet (annual, 2024-12-31) — Total Assets: 27720258000.00
UCB balance_sheet (annual, 2024-12-31) — Total Capitalization: 3686279000.00
UCB balance_sheet (annual, 2024-12-31) — Total Debt: 254152000.00
UCB balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 3432127000.00
UCB balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 24288131000.00
UCB income_statement (annual, 2024-12-31) — Total Unusual Items: -8623000.00
UCB income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -8623000.00
UCB income_statement (quarterly, 2025-03-31) — +Total Revenue: 242927000.00
UCB balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2711721000.00
UCB income_statement (quarterly, 2025-03-31) — Amortization: 3286000.00
UCB income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 3286000.00
UCB income_statement (quarterly, 2025-03-31) — Basic Average Shares: 120043000.00
UCB income_statement (quarterly, 2025-03-31) — Basic EPS: 0.58
UCB cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 519873000.00
UCB cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -4313000.00
UCB balance_sheet (quarterly, 2025-03-31) — Capital Stock: 207780000.00
UCB balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 636712000.00
UCB balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 636712000.00
UCB cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -30630000.00
UCB balance_sheet (quarterly, 2025-03-31) — Cash Financial: 198287000.00
UCB cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 74786000.00
UCB cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -56579000.00
UCB cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 98632000.00
UCB cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -40803000.00
UCB cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 19878000.00
UCB cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -40803000.00
UCB cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -735000.00
UCB cash_flow (quarterly, 2025-03-31) — Changes In Cash: 116839000.00
UCB balance_sheet (quarterly, 2025-03-31) — Common Stock: 119514000.00
UCB cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -29057000.00
UCB balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3412630000.00
UCB cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
UCB balance_sheet (quarterly, 2025-03-31) — Current Debt: 0.00
UCB balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 0.00
UCB cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 168000.00
UCB cash_flow (quarterly, 2025-03-31) — Deferred Tax: 168000.00
UCB cash_flow (quarterly, 2025-03-31) — Depreciation: 11448000.00
UCB cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 11448000.00
UCB income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 3286000.00
UCB cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 11448000.00
UCB income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 3286000.00
UCB balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 66244000.00
UCB income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 120201000.00
UCB income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.58
UCB income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 69429000.00
UCB cash_flow (quarterly, 2025-03-31) — End Cash Position: 636712000.00
UCB cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 74786000.00
UCB cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 94319000.00
UCB cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -6000.00
UCB income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 1662000.00
UCB balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -186559000.00
UCB income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 88909000.00
UCB balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 953357000.00
UCB balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 2338571000.00
UCB income_statement (quarterly, 2025-03-31) — Insurance And Claims: 4642000.00
UCB income_statement (quarterly, 2025-03-31) — Interest Expense: 123336000.00
UCB income_statement (quarterly, 2025-03-31) — Interest Income: 335357000.00
UCB balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3666917000.00
UCB cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -56579000.00
UCB balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 6661215000.00
UCB cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 126000000.00
UCB balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 254287000.00
UCB balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 254287000.00
UCB cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 126000000.00
UCB cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -126000000.00
UCB cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
UCB income_statement (quarterly, 2025-03-31) — Net Income: 71413000.00
UCB income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 69429000.00
UCB income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 71413000.00
UCB income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 71413000.00
UCB income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 71413000.00
UCB cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 71413000.00
UCB income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 71413000.00
UCB income_statement (quarterly, 2025-03-31) — Net Interest Income: 212021000.00
UCB cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 197222000.00
UCB cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -195000000.00
UCB cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
UCB cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -976000.00
UCB cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 4262000.00
UCB balance_sheet (quarterly, 2025-03-31) — Net PPE: 391020000.00
UCB cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -4313000.00
UCB cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -195000000.00
UCB balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2547539000.00
UCB income_statement (quarterly, 2025-03-31) — Normalized Income: 72428551.00
UCB income_statement (quarterly, 2025-03-31) — Occupancy And Equipment: 24628000.00
UCB cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 98632000.00
UCB cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1402000.00
UCB income_statement (quarterly, 2025-03-31) — Operating Revenue: 242927000.00
UCB balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 119514298.00
UCB balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 0.00
UCB balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -186559000.00
UCB balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 12983000.00
UCB income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 10417000.00
UCB balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 4322644000.00
UCB income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 411000.00
UCB balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 3662000.00
UCB balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 88266000.00
UCB cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: -1573000.00
UCB income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 1573000.00
UCB balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 88266000.00
UCB income_statement (quarterly, 2025-03-31) — Pretax Income: 91159000.00
UCB income_statement (quarterly, 2025-03-31) — Professional Expense And Contract Services Expense: 5931000.00
UCB cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -70092000.00
UCB cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -4313000.00
UCB income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 11448000.00
UCB cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -321000000.00
UCB cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
UCB income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 1297000.00
UCB balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 754971000.00
UCB income_statement (quarterly, 2025-03-31) — Salaries And Wages: 84267000.00
UCB cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 267314000.00
UCB income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1881000.00
UCB income_statement (quarterly, 2025-03-31) — Selling General And Administration: 90790000.00
UCB balance_sheet (quarterly, 2025-03-31) — Share Issued: 119514298.00
UCB cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -195000000.00
UCB income_statement (quarterly, 2025-03-31) — Special Income Charges: -1297000.00
UCB cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2321000.00
UCB balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3500896000.00
UCB balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2459273000.00
UCB income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -281449.00
UCB income_statement (quarterly, 2025-03-31) — Tax Provision: 19746000.00
UCB income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
UCB balance_sheet (quarterly, 2025-03-31) — Total Assets: 27873718000.00
UCB balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3755183000.00
UCB balance_sheet (quarterly, 2025-03-31) — Total Debt: 254287000.00
UCB balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3500896000.00
UCB balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 24372822000.00
UCB income_statement (quarterly, 2025-03-31) — Total Unusual Items: -1297000.00
UCB income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -1297000.00
UCB income_statement (quarterly, 2025-06-30) — +Total Revenue: 254339000.00
UCB balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 2764617000.00
UCB income_statement (quarterly, 2025-06-30) — Amortization: 3292000.00
UCB income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 3292000.00
UCB income_statement (quarterly, 2025-06-30) — Basic Average Shares: 121377000.00
UCB income_statement (quarterly, 2025-06-30) — Basic EPS: 0.63
UCB cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 636712000.00
UCB cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -12121000.00
UCB balance_sheet (quarterly, 2025-06-30) — Capital Stock: 209697000.00
UCB balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 561001000.00
UCB balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 574956000.00
UCB cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -30652000.00
UCB balance_sheet (quarterly, 2025-06-30) — Cash Financial: 201509000.00
UCB cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -318308000.00
UCB cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 159716000.00
UCB cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 96836000.00
UCB cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 849000.00
UCB cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -10631000.00
UCB cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 849000.00
UCB cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -9581000.00
UCB cash_flow (quarterly, 2025-06-30) — Changes In Cash: -61756000.00
UCB balance_sheet (quarterly, 2025-06-30) — Common Stock: 121431000.00
UCB cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -29079000.00
UCB balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3524658000.00
UCB cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -13942000.00
UCB balance_sheet (quarterly, 2025-06-30) — Current Debt: 0.00
UCB balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 0.00
UCB cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 3382000.00
UCB cash_flow (quarterly, 2025-06-30) — Deferred Tax: 3382000.00
UCB cash_flow (quarterly, 2025-06-30) — Depreciation: 11878000.00
UCB cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 11878000.00
UCB income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 3292000.00
UCB cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 11878000.00
UCB income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 3292000.00
UCB income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 121432000.00
UCB income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.63
UCB income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 76722000.00
UCB cash_flow (quarterly, 2025-06-30) — End Cash Position: 574956000.00
UCB cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -318308000.00
UCB cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 84715000.00
UCB cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -286000.00
UCB income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 858000.00
UCB balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -177170000.00
UCB income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 91742000.00
UCB balance_sheet (quarterly, 2025-06-30) — Goodwill: 925119000.00
UCB balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 974385000.00
UCB balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 2306730000.00
UCB income_statement (quarterly, 2025-06-30) — Insurance And Claims: 4745000.00
UCB income_statement (quarterly, 2025-06-30) — Interest Expense: 121834000.00
UCB income_statement (quarterly, 2025-06-30) — Interest Income: 347365000.00
UCB balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3679801000.00
UCB cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 159716000.00
UCB balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 6382053000.00
UCB cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
UCB balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 155143000.00
UCB balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 155143000.00
UCB cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
UCB cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -100000000.00
UCB cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -13942000.00
UCB income_statement (quarterly, 2025-06-30) — Net Income: 78733000.00
UCB income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 76722000.00
UCB income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 78733000.00
UCB income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 78733000.00
UCB income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 78733000.00
UCB cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 78733000.00
UCB income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 78733000.00
UCB income_statement (quarterly, 2025-06-30) — Net Interest Income: 225531000.00
UCB cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 325606000.00
UCB cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -100000000.00
UCB cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -100000000.00
UCB cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 184000.00
UCB cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 4674000.00
UCB balance_sheet (quarterly, 2025-06-30) — Net PPE: 396479000.00
UCB cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -12121000.00
UCB cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 0.00
UCB balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2638539000.00
UCB income_statement (quarterly, 2025-06-30) — Normalized Income: 82517239.00
UCB income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 24267000.00
UCB cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 96836000.00
UCB cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -2281000.00
UCB income_statement (quarterly, 2025-06-30) — Operating Revenue: 254339000.00
UCB balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 121431262.00
UCB balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 0.00
UCB balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -177170000.00
UCB balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 13190000.00
UCB balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 49266000.00
UCB income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 9395000.00
UCB balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 4075323000.00
UCB income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 438000.00
UCB balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 3662000.00
UCB balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 88266000.00
UCB cash_flow (quarterly, 2025-06-30) — Preferred Stock Dividend Paid: -1573000.00
UCB income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 1573000.00
UCB balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 88266000.00
UCB income_statement (quarterly, 2025-06-30) — Pretax Income: 100502000.00
UCB income_statement (quarterly, 2025-06-30) — Professional Expense And Contract Services Expense: 5609000.00
UCB cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -144460000.00
UCB cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -12121000.00
UCB income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 11878000.00
UCB cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -100000000.00
UCB cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -13942000.00
UCB income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 4833000.00
UCB balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 802590000.00
UCB income_statement (quarterly, 2025-06-30) — Salaries And Wages: 86997000.00
UCB cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 470066000.00
UCB income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 2881000.00
UCB income_statement (quarterly, 2025-06-30) — Selling General And Administration: 94623000.00
UCB balance_sheet (quarterly, 2025-06-30) — Share Issued: 121431262.00
UCB cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: 0.00
UCB income_statement (quarterly, 2025-06-30) — Special Income Charges: -4833000.00
UCB cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2887000.00
UCB balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3612924000.00
UCB balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2550273000.00
UCB income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -1048761.00
UCB income_statement (quarterly, 2025-06-30) — Tax Provision: 21769000.00
UCB income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.22
UCB balance_sheet (quarterly, 2025-06-30) — Total Assets: 28085521000.00
UCB balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3768067000.00
UCB balance_sheet (quarterly, 2025-06-30) — Total Debt: 155143000.00
UCB balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3612924000.00
UCB balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 24472597000.00
UCB income_statement (quarterly, 2025-06-30) — Total Unusual Items: -4833000.00
UCB income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -4833000.00
UCB income_statement (quarterly, 2025-09-30) — +Total Revenue: 270877000.00
UCB balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 2767143000.00
UCB income_statement (quarterly, 2025-09-30) — Amortization: 3313000.00
UCB income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 3313000.00
UCB cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
UCB income_statement (quarterly, 2025-09-30) — Basic Average Shares: 122116000.00
UCB income_statement (quarterly, 2025-09-30) — Basic EPS: 0.71
UCB cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 574956000.00
UCB cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -5386000.00
UCB balance_sheet (quarterly, 2025-09-30) — Capital Stock: 121553000.00
UCB balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 613431000.00
UCB balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 613431000.00
UCB cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -31114000.00
UCB balance_sheet (quarterly, 2025-09-30) — Cash Financial: 205007000.00
UCB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -65063000.00
UCB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -19557000.00
UCB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 123095000.00
UCB cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 3837000.00
UCB cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 7627000.00
UCB cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 3837000.00
UCB cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 13805000.00
UCB cash_flow (quarterly, 2025-09-30) — Changes In Cash: 38475000.00
UCB balance_sheet (quarterly, 2025-09-30) — Common Stock: 121553000.00
UCB cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -29541000.00
UCB balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 3596851000.00
UCB cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
UCB balance_sheet (quarterly, 2025-09-30) — Current Debt: 0.00
UCB balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 0.00
UCB cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -1430000.00
UCB cash_flow (quarterly, 2025-09-30) — Deferred Tax: -1430000.00
UCB cash_flow (quarterly, 2025-09-30) — Depreciation: 10784000.00
UCB cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 10784000.00
UCB income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 3313000.00
UCB cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 10784000.00
UCB income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 3313000.00
UCB income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 122252000.00
UCB income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.70
UCB income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 86139000.00
UCB cash_flow (quarterly, 2025-09-30) — End Cash Position: 613431000.00
UCB cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -65063000.00
UCB cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 117709000.00
UCB cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -49000.00
UCB income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 3736000.00
UCB balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -163923000.00
UCB income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 95513000.00
UCB balance_sheet (quarterly, 2025-09-30) — Goodwill: 925119000.00
UCB balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 971071000.00
UCB balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 2274099000.00
UCB income_statement (quarterly, 2025-09-30) — Insurance And Claims: 4846000.00
UCB income_statement (quarterly, 2025-09-30) — Interest Expense: 120221000.00
UCB income_statement (quarterly, 2025-09-30) — Interest Income: 353850000.00
UCB balance_sheet (quarterly, 2025-09-30) — Invested Capital: 3752102000.00
UCB cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -19557000.00
UCB balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 6163362000.00
UCB cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
UCB balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 155251000.00
UCB balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 155251000.00
UCB cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
UCB cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00